News
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Phase-3 clinical trial enrolment for India’s first dengue vaccine to be completed by October: ICMR
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...
We don't have $3.8 billion to spend on the pursuit of cures for illness but we have $75 billion for the work of ICE? What a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback